Concepedia

Angeliki Ditsiou

AD

Statistics

Publications

5

Citations

163

H-Index

5

Active since

2018

Affiliations

University of Sussex(Current)

Hammersmith Hospital

National Cancer Institute

Imperial College London

Angeliki Ditsiou is an author at University of Sussex specializing in molecular signaling, breast cancer, and tumor biology.

ORCID

Top concepts

Publications per year

2018–2021

5

Publications

5

PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression

Teresa Gagliano, Kalpit Shah, Sofia Gargani et al. · Journal of Clinical Investigation · 2020 · 50 citations · Full text

, , +18

LMTK3 confers chemo-resistance in breast cancer

Justin Stebbing, Kalpit Shah, Lei Cheng Lit et al. · Oncogene · 2018 · 43 citations · Full text

The structure-function relationship of oncogenic LMTK3

Angeliki Ditsiou, Chiara Cilibrasi, Nikiana Simigdala et al. · Science Advances · 2020 · 35 citations · Full text

Predominant patterns of splicing evolution on human, chimpanzee and macaque evolutionary lineages

Jieyi Xiong, Xi Jiang, Angeliki Ditsiou et al. · Human Molecular Genetics · 2018 · 21 citations · Full text

hMOB2 deficiency impairs homologous recombination-mediated DNA repair and sensitises cancer cells to PARP inhibitors

Ramazan Gündoğdu, Mehmet Kadir Erdoğan, Angeliki Ditsiou et al. · Cellular Signalling · 2021 · 14 citations · Full text

1–5 of 5